A-SYNAPTIC Trademark

Trademark Overview

On Thursday, May 6, 2021, a trademark application was filed for A-SYNAPTIC with the United States Patent and Trademark Office. The USPTO has given the A-SYNAPTIC trademark a serial number of 90694951. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2024. This trademark is owned by Gefion Canada, Inc. The A-SYNAPTIC trademark is filed in the Pharmaceutical Products category with the following description:

Medicated topical transdermal and transmucosal preparations sold to compounders for use in the treatment of childhood epilepsy, pain, severe arthritis pain, fibromyalgia pain, back pain, decubitus ulcers, post-traumatic stress, and migrant headaches; medicinal oral or sublingual spray preparations; medicated transdermal and transmucosal creams for use in the treatment of childhood epilepsy, pain, severe arthritis pain, fibromyalgia pain, back pain, decubitus ulcers, post-traumatic stress, and migrant headaches; oral and sublingual spray preparations for use in the treatment of childhood epilepsy, pain, severe arthritis pain, fibromyalgia pain, back pain, decubitus ulcers, post-traumatic stress, and migrant headaches; Medicated body lotion; Medicated body creams; Body lotion and body creams being medicated skincare preparations
a-synaptic

General Information

Serial Number90694951
Word MarkA-SYNAPTIC
Filing DateThursday, May 6, 2021
Status700 - REGISTERED
Status DateTuesday, March 12, 2024
Registration Number7324743
Registration DateTuesday, March 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2023

Trademark Statements

Goods and ServicesMedicated topical transdermal and transmucosal preparations sold to compounders for use in the treatment of childhood epilepsy, pain, severe arthritis pain, fibromyalgia pain, back pain, decubitus ulcers, post-traumatic stress, and migrant headaches; medicinal oral or sublingual spray preparations; medicated transdermal and transmucosal creams for use in the treatment of childhood epilepsy, pain, severe arthritis pain, fibromyalgia pain, back pain, decubitus ulcers, post-traumatic stress, and migrant headaches; oral and sublingual spray preparations for use in the treatment of childhood epilepsy, pain, severe arthritis pain, fibromyalgia pain, back pain, decubitus ulcers, post-traumatic stress, and migrant headaches; Medicated body lotion; Medicated body creams; Body lotion and body creams being medicated skincare preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 9, 2021
Primary Code005
First Use Anywhere DateMonday, August 28, 2023
First Use In Commerce DateMonday, August 28, 2023

Trademark Owner History

Party NameGefion Canada, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760
Party NameGefion Canada, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760
Party NameGefion Canada, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events

Event DateEvent Description
Monday, May 10, 2021NEW APPLICATION ENTERED
Monday, August 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Wednesday, June 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 22, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 31, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 31, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 19, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 19, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, May 19, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 22, 2023REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Monday, May 22, 2023NON-FINAL ACTION WRITTEN
Monday, May 22, 2023NON-FINAL ACTION E-MAILED
Monday, May 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 24, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 24, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, May 26, 2023NOTICE OF REINSTATEMENT E-MAILED
Thursday, October 26, 2023TEAS AMENDMENT OF USE RECEIVED
Thursday, October 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 27, 2023USE AMENDMENT FILED
Friday, October 27, 2023AMENDMENT TO USE PROCESSING COMPLETE
Friday, October 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 20, 2023USE AMENDMENT ACCEPTED
Monday, November 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 21, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, December 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, May 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 26, 2023PUBLISHED FOR OPPOSITION

Related Keywords

synaptic pain medicated body preparations ulcers post back stress creams headaches